| 1 |
LU1540961759 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD |
-0,84 % |
+18,72 % |
-0,16 |
| 2 |
LU2026682919 |
Candriam Equities L Biotechnology, V2 - Capitalisation |
+1,38 % |
+20,61 % |
-0,04 |
| 3 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
+1,15 % |
+20,59 % |
-0,05 |
| 4 |
LU1540962054 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD |
-1,35 % |
+19,55 % |
-0,18 |
| 5 |
LU0317020203 |
Candriam Equities L Biotechnology, V - Capitalisation |
+1,02 % |
+20,46 % |
-0,06 |
|
|
| 33 |
LU2208649280 |
UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse QL-acc, USD |
-5,53 % |
+22,09 % |
-0,35 |
|
|
| 79 |
LU0415392678 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I EUR - Accumulating |
-11,29 % |
+13,05 % |
-1,03 |
| 80 |
LU0415392249 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating |
-11,91 % |
+13,05 % |
-1,08 |
| 81 |
LU0767968745 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating |
-11,85 % |
+12,08 % |
-1,16 |
| 82 |
LU0415392835 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating |
-14,60 % |
+13,99 % |
-1,20 |
| 83 |
LU0415392595 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating |
-15,19 % |
+13,99 % |
-1,24 |